Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients

Hepatology

Volumn 27, Issue 1, 1998, Pages 223-227

  Booth, J C L ^a   Kumar, U ^a   Webster, D ^a   Monjardino, J ^a   Thomas, H C ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMINO ACID SEQUENCE; ARTICLE; CASE REPORT; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; HYPOGAMMAGLOBULINEMIA; MALE; PRIORITY JOURNAL; VIRUS CELL INTERACTION; VIRUS GENE;

EID: 0031982502     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510270134     Document Type: Article

References (24)

1. 1 Hijikata M, Kato N, Ootsuyama Y, Nakagawa M, Ohkoshi S, Shimohtohno K. Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Commun 1991 ; 175: 220–228. MEDLINE
2. 2 Ogata N, Alter HJ, Miller RH, Purcell RH. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci USA 1991 ; 88: 3392–3396. MEDLINE
3. 3 Weiner A, Brauer M, Rosenblatt J, Richman K, Tung J, Crawford K, Bonino F, et al. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus group glycoproteins. Virology 1991 ; 180: 842–848. MEDLINE
4. 4 Weiner AJ, Geysen M, Christopherson C, Hall JE, Mason TJ, Saracco G, Bonino F, et al. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci U S A 1992 ; 89: 3468–3472. MEDLINE
5. 5 Chien D, Choo Q‐L, Ralston R, Spaete R, Tong M, Houghton M, Kuo G. Persistence of HCV despite antibodies to both putative envelope glycoproteins. Lancet 1993 ; 342–933.
6. 6 Matsuura Y, Harada S, Suzuki R, Watanabe Y, Inoue Y, Saito I, Miyamura T. Expression of processed envelope protein of hepatitis C virus in mammalian and insect cells. J Virol 1992 ; 66: 1425–1431. MEDLINE
7. 7 Farci P, Alter H, Govindarajan S, Wong D, Engle R, Lesniewski R, Mushawar I, et al. Lack of protective immunity against reinfection with hepatitis C virus. Science 1992 ; 258: 135–140. MEDLINE
8. 8 Lai ME, Mazzoleni AP, Argiolu F, De Virgilis S, Balestrieri A, Purcell RH, Cao A, et al. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 1994 ; 343: 388–390. MEDLINE
9. 9 Kumar U, Monjardino J, Thomas H. Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in an agammaglobulinaemic patient. Gastroenterology 1994 ; 106: 1072–1075. MEDLINE
10. 10 Hermaszewski R, Webster A. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. QJM 1993 ; 86: 31–42.
11. 11 Chomczynski P, Sacchi N. Single‐step method of RNA isolation by acid guanidinium thiocyanate‐phenol‐chloroform extraction. Anal Biochem 1987 ; 162: 156–159. MEDLINE
12. 12 Maniatis T, Fritsch E, Sambrook J. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982.
13. 13 Sanger F, Nicklen S, Coulson A. DNA sequencing with chain‐terminating inhibitors. Proc Natl Acad Sci U S A 1977 ; 74: 5463–5467. MEDLINE
14. 14 Kumar U, Brown J, Monjardino J, Thomas H. Sequence variation in the large envelope glycoprotein (E2/NS1) of hepatitis C virus during chronic infection. J Infect Dis 1993 ; 167: 726–730. MEDLINE
15. 15 Okamoto H, Kojima M, Okada S‐I, Yoshizawa H, Iizuka H, Tanaka T, Muchmore E, et al. Genetic drift of hepatitis C virus during an 8.2‐year infection in a chimpanzee: variability and stability. Virology 1992 ; 190: 894–899. MEDLINE
16. 16 Taniguchi S, Okamoto H, Sakamoto M, Kojima M, Tsuda F, Tanaka T, Munekata E, et al. A structurally flexible and antigenically variable N‐terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody. Virology 1993 ; 195: 297–301. MEDLINE
17. 17 Kato N, Sekiya H, Ootsuyama Y, Nakazawa T, Hijikata M, Ohkoshi S, Shimotohno K. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp 70) of hepatitis C virus. J Gen Virol 1993 ; 67: 3923–3930.
18. 18 Van Doorn L‐J, Capriles I, Maertens G, DeLeys R, Murray K, Kos T, Schellekens H, et al. Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses. J Virol 1995 ; 69: 773–778. MEDLINE
19. 19 Wolfs T, de Jong J‐J, van den Berg H, Tijnagel J, Krone W, Goudsmit J. Evolution of sequences encoding the principal neutralization epitope of human immunodeficiency virus 1 is host dependent, rapid and continuous. Proc Natl Acad Sci U S A 1990 ; 87: 9938–9942. MEDLINE
20. 20 Koziel M, Dudley D, Afdhal N, Choo Q‐L, Houghton M, Ralston R, Walker B. Hepatitis C virus (HCV)‐specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol 1993 ; 67: 7522–7532. MEDLINE
21. 21 Lesniewski R, Boardway K, Casey J, Desai S, Devare S, Leung T, Mushawar I. Hypervariable 5′‐terminus of hepatitis C virus E2/NS1 encodes antigenically distinct variants. J Med Virol 1993 ; 40: 150–156. MEDLINE
22. 22 Okada S‐I, Akahane Y, Suzuki H, Okamoto H, Mishiro S. The degree of variability in the amino terminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to Interferon therapy in viremic patients. Hepatology 1992 ; 16: 619–624. MEDLINE
23. 23 Sakamoto N, Enomoto N, Kurosaki M, Marumo F, Sato C. Sequential change of the hypervariable region of the hepatitis C virus genome in acute infection. J Med Virol 1994 ; 42: 103–108. MEDLINE
24. 24 Bjoro K, Froland S, Yun Z, Samdal H, Haaland T. Hepatitis C infection in patients with primary hypogammaglobulinaemia after treatment with contaminated immune globulin. N Engl J Med 1994 ; 331: 1607–1611. MEDLINE